# EIF2S2

## Overview
EIF2S2 is a gene that encodes the eukaryotic translation initiation factor 2 subunit beta (eIF2β), a critical component of the eIF2 complex involved in the initiation of protein synthesis in eukaryotic cells. The eIF2β protein is part of a heterotrimeric complex that includes eIF2α and eIF2γ, and it plays a pivotal role in forming a ternary complex with GTP and Met-tRNA, which is essential for the binding of ribosomes to mRNA during translation initiation (bertolessi2017differential). As a regulatory protein, eIF2β undergoes post-translational modifications, such as phosphorylation, which influence its function and interactions with other molecular components, thereby impacting protein synthesis and cellular responses to stress. The gene's expression and regulation are significant in various cellular processes and have been implicated in the pathogenesis of diseases such as gliomas and hepatocellular carcinoma, where its altered expression levels are associated with tumor progression and prognosis (Marina2019Relevance; chen2022EIF2S3).

## Structure
EIF2S2, or eukaryotic translation initiation factor 2 subunit beta, is a crucial component of the eIF2 complex, which plays a significant role in the initiation of protein synthesis. The primary structure of EIF2S2 consists of a specific sequence of amino acids that form the foundation for its higher-level structures. The secondary structure of EIF2S2 includes both alpha helices and beta sheets, which contribute to its stability and function within the eIF2 complex. 

The tertiary structure of EIF2S2 refers to its overall three-dimensional shape, which is essential for its interaction with other molecular components. In terms of quaternary structure, EIF2S2 interacts with other subunits within the eIF2 complex, facilitating its role in translation initiation. 

Post-translational modifications, such as phosphorylation, are common in EIF2S2 and play a regulatory role in its activity. These modifications can influence the protein's function and its interactions with other molecules, thereby impacting the overall process of protein synthesis. The structural features and modifications of EIF2S2 are integral to its function in the eIF2 complex, highlighting its importance in cellular processes.

## Function
EIF2S2 encodes the beta subunit of the eukaryotic translation initiation factor 2 (eIF2), which is essential for the initiation of protein synthesis in eukaryotic cells. This protein is a part of a heterotrimeric complex that includes eIF2S1 (eIF2α) and eIF2S3 (eIF2γ). The eIF2 complex plays a critical role in the initiation of translation by forming a ternary complex with GTP and Met-tRNA, facilitating the binding of the ribosome to mRNA (bertolessi2017differential).

In healthy cells, EIF2S2 is involved in binding GTP, mRNA, and Met-tRNA, and interacts with other factors such as eIF5 and eIF2B, which are crucial for the regulation of translation initiation. The N-terminal of eIF2S2 is highly phosphorylated, which may influence GTP hydrolysis, a key step in translation initiation (bertolessi2017differential). This process is vital for cellular growth, proliferation, and response to stress, as it ensures the proper synthesis of proteins necessary for these functions.

EIF2S2 is active in the cytoplasm, where translation occurs, highlighting its role in the cellular machinery that governs protein synthesis and overall cellular function (bertolessi2017differential).

## Clinical Significance
EIF2S2 is implicated in various diseases through alterations in its expression levels. In gliomas, a type of brain tumor, EIF2S2 is upregulated, which may contribute to the pathogenesis of these tumors by affecting mRNA translation and cellular stress responses (Marina2019Relevance). This upregulation is particularly noted in glioblastoma multiforme, where it is associated with the mesenchymal subtype, suggesting a role in tumor progression and aggressiveness.

In hepatocellular carcinoma (HCC), EIF2S2 is also upregulated and is linked to poor prognosis. Its overexpression in HCC is associated with clinicopathological features that predict adverse outcomes, indicating its potential as a prognostic biomarker (chen2022EIF2S3). The gene's involvement in translation initiation and its correlation with immune cell infiltration in HCC further highlight its clinical significance in cancer biology (chen2022EIF2S3).

Additionally, genetic studies have shown that the absence of Ataxin-2, which affects RNA processing and translation, leads to the upregulation of EIF2S2, suggesting a compensatory mechanism in response to altered translation dynamics (Fittschen2015Genetic). This relationship underscores the complex regulatory networks involving EIF2S2 and its potential impact on disease states.


## References


[1. (Fittschen2015Genetic) M. Fittschen, I. Lastres-Becker, M. V. Halbach, E. Damrath, S. Gispert, M. Azizov, M. Walter, S. Müller, and G. Auburger. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. neurogenetics, 16(3):181–192, February 2015. URL: http://dx.doi.org/10.1007/s10048-015-0441-5, doi:10.1007/s10048-015-0441-5. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-015-0441-5)

[2. (Marina2019Relevance) Digregorio Marina, Lombard Arnaud, Lumapat Paul Noel, Scholtes Felix, Rogister Bernard, and Coppieters Natacha. Relevance of translation initiation in diffuse glioma biology and its therapeutic potential. Cells, 8(12):1542, November 2019. URL: http://dx.doi.org/10.3390/cells8121542, doi:10.3390/cells8121542. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8121542)

3. (chen2022EIF2S3) EIF2S3 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma. This article has 0 citations.

4. (bertolessi2017differential) Maíra Bertolessi Lourenço. Differential proteomics and early neuronal differentiation of MEHMO patient-derived iPSCs. PhD thesis, Universität Tübingen, 2017. This article has 0 citations.